Delhi HC refuses FMC’s plea to stop Natco’s Cyantraniliprole commercialization
Delivering judgment on 17 November 2025, Justice Mini Pushkarna dismissed FMC’s application under Order XXXIX Rules 1 and 2 CPC in CS(COMM)…
Delivering judgment on 17 November 2025, Justice Mini Pushkarna dismissed FMC’s application under Order XXXIX Rules 1 and 2 CPC in CS(COMM)…
Sumitomo’s Indian patent application, IN 3570/CHENP/2011 with title “Composition For Controlling Plant Diseases And Method For Controlling Plant Diseases” covering combination (mixture)…
Overview To make up for arbitrary delays in the issuing of patents by the Canadian Intellectual Property Office, Canada has passed laws…
FMC QUÍMICA DO BRASIL LTDA filed International PCT Patent Application (WO2016015113 A1) covering Triazolinone Herbicide Sulfentrazone Herbicide Diuron Mixture (synergistic herbicidal formulation),…
Summary : Johnson & Johnson and Momenta Pharmaceuticals lawsuit alleges infringement of two old patents associated with 20mg/ml and 40mg/ml Glatiramer Acetate…
Summary : The Hangzhou Intermediate People’s Court in Zhejiang Province, China, awarded FMC a permanent injunction against Hangzhou Udragon Chemical Co., Ltd…
Summary: On February 8, 2022, the National Institute of Industrial Property (INPI) published a notice in Gazette 2666 detailing new rules for…
Summary : A federal jury has awarded biotechnology company Seagen Inc. $41.8 million in a patent infringement lawsuit against Daiichi Sankyo Co.…
Summary : EP 1,427,415 was assigned to BMS and is set to expire on September 17, 2022. On May 19, 2026, the…
Summary : Janssen Pharmaceutical, a division of Johnson & Johnson, won an arbitrary victory against royalty choices arising from the licencing and…